The role of biotransformation processes in mediating interactions between psychotropic drugs and natural products by Bacinschi, Nicolae et al.
Journal of Mind and Medical Sciences 
Volume 7 Issue 1 Article 3 
2020 
The role of biotransformation processes in mediating interactions 
between psychotropic drugs and natural products 
Nicolae Bacinschi 
NICOLAE TESTEMITANU STATE UNIVERSITY OF MEDICINE AND PHARMACY, FACULTY OF MEDICINE, 
DEPARTMENT OF PHARMACOLOGY AND CLINICAL PHARMACOLOGY, CHIȘINĂU, REPUBLIC OF 
MOLDOVA. 
Ina Pogonea 
NICOLAE TESTEMITANU STATE UNIVERSITY OF MEDICINE AND PHARMACY, FACULTY OF MEDICINE, 
DEPARTMENT OF PHARMACOLOGY AND CLINICAL PHARMACOLOGY, CHIȘINĂU, REPUBLIC OF 
MOLDOVA. 
Lilia Podgurschi 
NICOLAE TESTEMITANU STATE UNIVERSITY OF MEDICINE AND PHARMACY, FACULTY OF MEDICINE, 
DEPARTMENT OF PHARMACOLOGY AND CLINICAL PHARMACOLOGY, CHIȘINĂU, REPUBLIC OF 
MOLDOVA. 
Maria Mihalachi-Anghel 
NICOLAE TESTEMITANU STATE UNIVERSITY OF MEDICINE AND PHARMACY, FACULTY OF MEDICINE, 
DEPARTMENT OF PHARMACOLOGY AND CLINICAL PHARMACOLOGY, CHIȘINĂU, REPUBLIC OF 
MOLDOVA. 
Emil Ștefănescu 
CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, FACULTY OF PHARMACY, DEPARTMENT OF 
PHARMACOLOGY AND CLINICAL PHARMACY, BUCHAREST, ROMANIA. 
See next page for additional authors 
Follow this and additional works at: https://scholar.valpo.edu/jmms 
 Part of the ndocrinology, Diabetes, and Metabolism Commons, Integrative Medicine Commons, 
Neurology Commons, Preventive Medicine Commons, Psychiatric and Mental Health Commons, 
Psychiatry Commons, and the Substance Abuse and Addiction Commons 
Recommended Citation 
Bacinschi, Nicolae; Pogonea, Ina; Podgurschi, Lilia; Mihalachi-Anghel, Maria; Ștefănescu, Emil; Socea, 
Bogdan; and Chianu, Marin (2020) "The role of biotransformation processes in mediating interactions 
between psychotropic drugs and natural products," Journal of Mind and Medical Sciences: Vol. 7 : Iss. 1 , 
Article 3. 
DOI: 10.22543/7674.71.P915 
Available at: https://scholar.valpo.edu/jmms/vol7/iss1/3 
This Review Article is brought to you for free and open access by ValpoScholar. It has been accepted for inclusion 
in Journal of Mind and Medical Sciences by an authorized administrator of ValpoScholar. For more information, 
please contact a ValpoScholar staff member at scholar@valpo.edu. 
The role of biotransformation processes in mediating interactions between 
psychotropic drugs and natural products 
Authors 
Nicolae Bacinschi, Ina Pogonea, Lilia Podgurschi, Maria Mihalachi-Anghel, Emil Ștefănescu, Bogdan 
Socea, and Marin Chianu 
This review article is available in Journal of Mind and Medical Sciences: https://scholar.valpo.edu/jmms/vol7/iss1/3 
To cite this article: Nicolae Bacinschi, Ina Pogonea, Lilia Podgurschi, Maria Mihalachi-Anghel, Emil Ștefănescu, Bogdan Socea, 
Marin Chianu. The role of biotransformation processes in mediating interactions between psychotropic drugs and natural products. 
J Mind Med Sci. 2020; 7(1): 9-15. DOI: 10.22543/7674.71.P915  
 
 Journal of Mind and Medical Sciences 
 
https://scholar.valpo.edu/jmms/  
https://proscholar.org/jmms/  
I S S N :  2 3 9 2 - 7 6 7 4  
 
 
 
 
The role of biotransformation processes in mediating interactions 
between psychotropic drugs and natural products 
 Nicolae Bacinschi
1, Ina Pogonea1*, Lilia Podgurschi1, Maria Mihalachi-Anghel1, 
Emil Ștefănescu2, Bogdan Socea3, Marin Chianu1 
 
1
NICOLAE TESTEMITANU STATE UNIVERSITY OF MEDICINE AND PHARMACY, FACULTY OF MEDICINE, DEPARTMENT OF PHARMACOLOGY AND CLINICAL PHARMACOLOGY, CHIȘINĂU,  
  REPUBLIC OF MOLDOVA. 
2
CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, FACULTY OF PHARMACY, DEPARTMENT OF PHARMACOLOGY AND CLINICAL PHARMACY, BUCHAREST, ROMANIA. 
3
CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, ST. PANTELIMON EMERGENCY CLINICAL HOSPITAL, DEPARTMENT OF SURGERY, BUCHAREST, ROMANIA. 
 
A B ST R AC T 
 
A R T IC LE D A T A 
Many patients are not aware that natural products such as fruit juices or plant 
infusions can cause significant interactions with several drugs, some of 
which can be dangerous, especially when the medical treatment is for 
neurological or psychiatric disorders. Among the most predisposed for 
interacting with drugs are citric juices, particularly grapefruit and plant 
infusions, especially St John`s wort (Hypericum perforatum). Understanding 
the mechanism and the frequency of this type of interaction helps to avoid 
it. The goal of this research was to identify and summarize the most relevant 
reports on interactions between psychotropic drugs and natural beverages, 
in order to raise awareness among physicians that they should invest more 
time in educating patients how to administer drugs properly, thus reducing 
the likelihood of such unwanted events. For the purpose of this study, an 
electronic search of PubMed database was conducted until September 2019. 
We concluded that natural beverage consumption along side medical 
treatment is a widespread practice and the main mechanism generating 
interactions is related to the functioning of biotransformation enzymes. 
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Introduction 
Often physicians are asked if drugs can be taken with 
drinks other than water, such as fruit and vegetable juices or 
tea, for better compliance, especially by pediatric and geriatric 
patients. The latest research in the field shows that 
concomitant use of single drugs and certain juices or plant 
infusions can influence the efficiency of medicines decreasing 
it or even worse, enhancing it excessively [1-4]. 
How can this type of phenomenon be explained? As we 
know, drugs are used for their pharmacological effect, but 
most are foreign substances for the human body and 
undergo various biotransformations in order to be 
inactivated and eliminated. It is well known that most drugs 
are metabolized with the help of vital enzymes called liver 
microsomal enzymes (cytochrome P450), but also with 
other blood or tissue enzymes [5-9]. 
Discussions 
Cytochrome is a complex protein, containing iron and 
a prosthetic group represented by the heme, often called 
hemoprotein. The group was first described in 1886 by 
C.A. MacMunn as the histohematin, but its role in living 
cells remained unclear until 1925 when the group had been 
reanalyzed by D. Keilin [10,11]. Since then, vast 
knowledge about cytochromes has accumulated regarding 
their role in living organisms. 
Cytochromes are widespread in plant and animal cells 
and in some microorganisms, such as yeasts and some 
facultative anaerobes. Linked to mitochondrial membranes, 
endoplasmic reticulum, chloroplasts and chromatophores, 
they play an important role in many processes that occur in 
living organisms, such as cellular respiration, photosynthesis 
and microsomal oxidation [12, 13]. 
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All cytochromes are able to donate and accept electrons 
through a reversible change in the valence of iron atoms in 
heme molecules. Combined in short or long chains, 
depending on the potential of the final electron acceptor, 
cytochromes transport electrons from dehydrogenases to 
final acceptors. The transport of electrons from cytochrome 
to cytochrome allows the cell to use the energy of chemical 
compounds or sunlight in all vital processes. For example, 
as part of the mitochondrial respiratory enzyme chain, 
cytochromes, together with cytochrome oxidase, carry out 
the final oxidation steps of the substrates. The energy 
released in this process is used to form adenosine 
triphosphate (ATP) or to generate a membrane potential. 
Cytochromes in the endoplasmic reticulum form non-
phosphorylated short chains that are part of a system 
responsible for metabolizing and neutralizing aromatic 
compounds [14-16]. 
The cytochromes are divided into four types - a, b, c 
and d - depending on the spectral characteristics, the 
chemical structure of the heme side chains and the nature 
of the link between the heme and the protein molecule. 
Each type, in turn, is further subdivided into several 
subtypes. The cytochromes whose individuality has been 
established are designated by a Latin letter in lowercase, 
indicating the group to which the cytochrome belongs and 
with an index number, for example, cytochrome c1. In a 
reduced state, cytochromes form a distinct spectrum with 
three pronounced absorption bands, characteristic of each 
type of cytochrome and useful in identifying cytochromes 
by spectrophotometric methods [17-19]. 
About 30 cytochromes are known, but only a few have 
been obtained as individual proteins. It is difficult to obtain 
highly purified cytochromes as they are strongly bound to 
membranes and can only be separated by treatment with 
surfactants or proteolytic enzymes. Cytochromes b3 and c 
are exceptions because they can be easily extracted with 
saline solutions [19, 20]. 
A comparison of the amino acid sequence of the protein 
part of the cytochrome c molecule obtained from different 
organisms reveals that the amino acid residue sequences of 
35 and 11 in different parts of the chain remain unchanged. 
The number of exchanges in other parts of the protein chain 
of this cytochrome obtained from different species of 
organisms is directly related to the phylogenetic 
differences between species [21]. For example, the 
molecules of cytochrome c from horse and yeasts differ in 
48 amino acid residues, while ducks and chickens differ 
only in two; those of pigs, cows and sheep are identical. 
Through these enzymes a very important role is 
played by the complex of hepatic cytochrome P 450 
divided into several sub-families: A, C, E. The basic role 
of this cytochrome is to ensure the metabolism of 
xenobiotics. However, the activity of these enzymes can 
be modified by the xenobiotic itself as well as by many 
other factors such as additional drugs, plant juices, 
ethanol, various foods or even cigarette smoke [1, 22-25]. 
The nature of these changes can be in the direction of 
intensifying the activity, as well as in diminishing it. The 
process of intensifying the activity of such an enzyme 
system is known as enzymatic induction and results in a 
faster metabolization of a xenobiotic, which in turn may 
lower the intensity and duration of its pharmacological 
effect. The process of reducing the activity of a 
biotransformation enzyme system is known as enzymatic 
inhibition and results in a slower metabolization of a 
xenobiotic, which in turn may increase the intensity and 
duration of its pharmacological effect [26, 27].  
Based on these considerations, any substance 
administered concurrently with a drug may alter its efficacy 
and this would require reviewing the dosage of the drug or 
the time between 2 consecutive doses. The CYP3A4 
cytochrome is responsible for the biotransformation of most 
xenobiotics and is highly susceptible to enzymatic induction 
or inhibition. Therefore, any food or beverage, being a 
xenobiotic, can influence the activity of cytochrome P450 
enzymes [28, 29]. 
Taking into account that many nutritionists encourage 
natural juice consumption on a daily bases due to the 
undeniable richness in various nutrients, vitamins and 
microelements in these products, it is pertinent to wonder 
whether they influence the efficacy of drugs [30]. 
Daily consumption of fruits and vegetables, preferably 
raw or in the form of salads or juices is part of a normal, 
healthy and balanced diet, which promotes the proper 
functioning of the immune system [31] and can prevent the 
onset of many nutrition related illnesses such as obesity 
and diabetes, which are increasingly studied by researchers 
to develop new pharmacological remedies [32,33]. 
However, a rising number of studies are revealing that 
medical treatment can be significantly influenced by some 
compounds found in various natural beverages or foods.  
Scientists have observed for several decades that drugs 
administered with grapefruit juice, containing naringin 
(that turns to naringenin in the liver) or orange juice, 
containing hesperidin, both substances inhibitors of 
cytochrome P450, will metabolize at a slower speed. This 
phenomenon can occur even after the ingestion of no more 
than 200 mL of juice. Administering drugs at standard 
intervals when biotransformation processes are slowed 
down can lead to their accumulation in the body. This 
amplifies side effects and can even trigger drug overdose 
[34-38]. 
Thus, for example, if a patient uses grapefruit juice 
while taking some statins for lowering cholesterol blood 
levels, a fraction of the drug fails to metabolize, increasing 
the risk of liver and muscle damage, which could lead, 
finally, to renal failure [39, 40]. It turns out that the 
grapefruit juice inhibits several hepatic microsomal 
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enzymes responsible for the inactivation of at least 40 
drugs administered in humans [41]. Pomegranate juice has 
also shown CYP3A4 inhibition properties, just like 
grapefruit juice [42]. 
It has also been demonstrated that, alongside grapefruit 
juice, other fruit juices, especially apple and orange juice, 
can also significantly alter the efficacy of many drugs [43, 
44]. It is assumed that they are inhibitors of the intestinal 
organic anion transporting polypeptide (OATP), which 
helps in the absorption process of some drugs [45-47]. 
Inhibiting the intestinal OATP results in reduced 
absorption and increased probability of low serum levels of 
drugs transported by OATP [48-50]. Other studies have 
shown that citric juices also inhibit the intestinal efflux P-
glycoprotein (PGP), thus increasing the oral bioavailability 
of other drugs [51].  
The juices from lemon and pomelo are susceptible to 
drug interactions similar to grapefruit by inhibiting 
intestinal CYP3A4 [52]. Recently it has been shown that 
even tomato juice, used extensively in the food industry, 
also has an inhibitory action on cytochrome P450 CYP3A4 
[22]. 
It should be noted that the amount of microsomal 
enzymes varies from person to person and is genetically 
determined [53]. Accordingly, juices can influence the 
efficacy of drugs differently in people who receive the 
same medicine but are of different ages or ethnic groups. 
A wide range of drugs used in daily psychiatric practice 
undergo phase I oxidation with CYP3A4, CYP1A2 or 
CYP2C19 such as anxiolytics, antidepressants, mood 
stabilizers, antipsychotics or neurotonic compounds and 
are susceptible to interactions with several natural 
products. The highest number of reports regarding such 
interactions is related to grapefruit juice and the 
mechanism of interaction has to do with the influence of 
some ingredients from grapefruits on hepatic metabolism 
but also on enteric absorption pathways using PGP and 
OATP, as we have already shown. The risk of dangerous 
consequences is particularly important when taking 
psychotropic drugs with natural products that can alter the 
pharmacological effect of drugs. For instance, grapefruit 
juice consumption increases the mean peak plasma 
concentrations and the area below the concentration – time 
curve of sertraline [54] and fluvoxamine [55]. Therefore, 
grapefruit juice is generally contraindicated to patients 
under psychiatric treatment and it is advised to inform 
patients about the nature of these possible interactions [56]. 
Antidepressant activity of monoamine oxidase 
inhibitors (MAOIs) was initially noted in the 1950s. 
Although older MAOIs are effective in the treatment of 
depressive disorders, they are under-utilized in clinical 
practice due to concerns about interaction with tyramine-
containing food (matured cheese, red vine, ripened 
bananas, yogurt, shrimp paste and salami) – the so called 
“cheese reaction”, since it can induce a hypertensive crisis 
in patients taking MAOIs [57]. 
The first-generation MAOIs such as phenelzine and 
isocarboxazid were largely nonselective inhibitors of both 
subtypes of MAO: MAO (A) and MAO (B). These drugs 
carried with them dietary restrictions [58]. Tyramine is an 
indirectly acting sympathomimetic agent, is degraded by 
MAO but in the presence of nonselective MAOIs, it 
escapes degradation and reaches the systemic circulation 
where it produces vascular constriction, leading to a 
hypertensive crisis [59]. However, MAOIs have been well 
established as an effective intervention for people with 
treatment-resistant depression, and transdermal 
formulations of selective MAO (B) inhibitors may provide 
a valuable therapeutic option and minimize the drug-food 
interactions [60]. 
Taking into account that the prevalence of anxiety 
disorders, depression and even epilepsy is rising around the 
world, it is important to assess and underline the risk of 
interactions between the most prescribed drugs for these 
illnesses and the most consumed natural products such as 
citric juices or herbal infusions: 
Benzodiazepines – There have been mixed reports on 
the degree to which grapefruit juice interacts with a variety 
of anxiolytics. A Turkish research group revealed that one 
glass of grapefruit juice more than triples the 
bioavailability of diazepam [61], while a Swiss study [62] 
has shown grapefruit juice increasing the bioavailability of 
oral midazolam by 50%. Hukkinen et al [63] showed an 
increase in the serum concentration of triazolam by a factor 
of 1.3. These studies, however, are contradicted by 
Vanakoskiet et al who found no effect on bioavailability of 
midazolam or triazolam by grapefruit juice [64].  
Another natural beverage with a significant potential to 
influence the effect of benzodiazepines is the Hypericum 
perforatum infusion. An open-label crossover study 
conducted on 12 healthy volunteers revealed a 2-fold 
decrease in the area under the curve for alprazolam plasma 
concentration vs time and a 2-fold increase in alprazolam 
clearance after a 2-week period of St John`s wort tea 
consumption [65].  
For the above mentioned 4 benzodiazepines, patients 
should avoid drinking grapefruit juice or John`s wort tea 
during treatment in order to avoid similar interactions.  
Buspirone is an azapirone anxiolytic agent that 
produces less sedation and impairment of psychomotor 
performance than benzodiazepines do. It has poor 
bioavailability due to extensive first-pass metabolism. 
Moderate quantities of grapefruit juice have been shown to 
raise the mean peak plasma concentration of buspirone 4.3-
fold and the mean area under the plasma buspirone 
concentration-time curve 9.2-fold [66]. It would be wise to 
counsel patients to avoid the co-administration of 
buspirone with grapefruit juice, particularly in large 
amounts (more than 3 glasses per day). 
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Sertraline, a selective serotonin reuptake inhibitor 
used in the treatment of depression, panic disorder, and 
obsessive-compulsive disorder, undergoes first-pass 
metabolism by CYP3A4. A thorough study has shown both 
in vitro and in vivo evidence of grapefruit juice inhibiting 
this metabolism [67]. Four of the study's 5 patients had 
sertraline levels increased by approximately 1.5-fold when 
1 glass of regular-strength grapefruit juice was drunk daily.  
Hypericum perforatum infusion has also been found to 
influence the activity of antidepressant drugs as well as 
anxiolytics active on the serotonin transmission, such as 
buspirone [68]. Studies have shown that some active 
ingredients in this plant inhibit MAO activity and induce 
an up-regulation of 5-HT2 receptors in the frontal cortex 
[69]. Under these circumstances, consuming a tea 
containing a St John`s wort infusion while under treatment 
with serotonin reuptake inhibitors may trigger a 
serotoninergic syndrome [70]. 
Clomipramine is a tertiary tricyclic amine 
antidepressant also used in the treatment of obsessive-
compulsive disorder. Oesterheld and Kallepalli [71] 
reported their experience of using grapefruit juice to 
elevate the drug levels of clomipramine and improve 
efficacy in 2 children with obsessive-compulsive disorder. 
The authors postulated that in some patients, 
demethylation of clomipramine may be largely mediated 
by the CYP3A4 system. However, in most patients, up to 
5 isoforms of cytochrome P450 with different sensitivities 
to enzymatic inhibitors are involved in the 
biotransformation of this drug [72].  
In the case of psychotropic drugs, the inhibitory effect 
of grapefruit juice on the CYP3A4 cytochrome is of equal 
importance with its influence on OATPs and especially 
PGPs due to the fact that PGP is one of the most important 
transporters for drugs active in the central nervous system, 
regulating their absorption and elimination [73, 74]. 
Methadone is a synthetic μ-opioid receptor agonist 
used for treating the withdrawal syndrome in heroin 
addicts, but also for chronic pain. The main 
biotransformation pathway of this drug is via CYP3A4 
which is significantly induced by St John`s wort. A study 
investigating the influence of this natural product on 
methadone serum concentrations uncovered an average 
decrease of 47% when patients ingested St John`s wort tea 
repeatedly [75]. On the other hand, in the presence of 
grapefruit juice, the area under the concentration – time 
curve increases by an average of 17% which could lead to 
symptoms of overdosing in some patients [76].  
Carbamazepine, an anticonvulsant widely used in the 
treatment of epilepsy, when co-administered with a large 
glass (300 mL) of fresh grapefruit juice increased the 
steady-state peak concentration of carbamazepin by 40% 
and the area under the plasma concentration-time curve by 
41%, leading to drowsiness and confusion [77]. Given 
carbamazepine's narrow therapeutic index, it is wise to 
avoid the potential toxic effects induced by the co-
administration of grapefruit juice. 
Highlights 
Biotransformation enzymes play an important role in 
determining the intensity and duration of the 
pharmacological effect of drugs. 
Several natural juices or plant infusions contain 
compounds capable to influence the activity of 
biotransformation enzymes, thus altering drug 
pharmacokinetics and pharmacodynamics, causing either 
relative overdosing, or relative underdosing. 
Conclusions 
In light of the above findings we can conclude that 
people under treatment with various drugs, especially 
psychotropic drugs, should consult their doctor before 
administering them with fruit juices or plant infusions. 
Underdosing or overdosing psychotropic drugs can lead to 
unpredictable consequences, and therefore extreme caution 
is required. Taking into account the fact that many 
interactions are not yet fully known, patients should be 
given the medication only with water if possible, and 
should be encouraged to report any new side effect that 
occurs when drugs are administered with natural beverages 
other than water.  
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